OTSKY.US Otsuka Holdings Co Ltd ADR

Healthcare Pharmaceuticals USA Stocks
38.57 USD
Close of Nov 15, 2026
25.61 40.92
Market cap
USD 40.4B
P/E
16.6x
P/B
2.01x
ROE
13.5%
Dividend yield
1.38%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is OTSKY.US undervalued?

Graham number
Price38.57
Graham value31.75
Premium21.5%

OTSKY.US trades 21.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Otsuka Holdings Co Ltd ADR fundamental analysis

No fundamental analysis for Otsuka Holdings Co Ltd ADR yet.

Otsuka Holdings Co Ltd ADR stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Otsuka Holdings Co Ltd ADR

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products…

Full company profile